**Core Concept:** Angioedema is a clinical condition characterized by localized swelling of the skin, mucous membranes, and subcutaneous tissues. It is caused by bradykinin accumulation due to deficiency or inactivation of specific enzymes or proteins.

**Why the Correct Answer is Right:** Angioedema is primarily caused by a deficiency of **C1 inhibitor** (C1-INH), which is a serine protease inhibitor. C1-INH plays a crucial role in the regulation of the classical complement pathway and the contact system (kallikrein-kinin system). Its deficiency results in increased bradykinin production, leading to angioedema symptoms.

**Why Each Wrong Option is Incorrect:**

A. Deficiency of **C4** is not directly linked to angioedema. C4 is a component of the classical complement pathway, not the contact system.
B. Deficiency of **C1r** or **C1s** is also unrelated to angioedema, as they are components of the classical complement pathway.
C. Deficiency of **C3** is connected to the classical complement pathway, but not to angioedema. C3 is an essential component of the alternative pathway and not directly involved in bradykinin regulation.
D. Deficiency of **mannose-binding lectin** (MBL) is associated with MBL-deficiency syndrome, which is distinct from angioedema and involves complement activation via the lectin pathway.

**Clinical Pearl:** Angioedema can also be caused by other factors, such as hereditary or acquired C1-INH deficiency, use of medications like ACE inhibitors, or allergic reactions. However, the correct answer focuses on the most common cause, which is the deficiency of C1-INH.